28
Views
1
CrossRef citations to date
0
Altmetric
Original Paper

Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease

, , &
Pages 26-29 | Published online: 08 Jul 2009

References

  • Roede J, Harris FP, Probst R, Xu L. Repeatability of distortion product otoacoustic emissions in normally hearing humans. Audiol 1993; 32: 273–81.
  • Probst R, Harris FP, Hauser R. Clinical monitoring using otoacoustic emissions. Br J Audiol 1993; 27: 85–90.
  • Ress BD, Sridhar KS, Balkany TJ, Waxman GM, Stagner BB, Lonsbury-Martin BL. Effects of cis-plati-num chemotherapy on otoacoustic emissions: The development of an objective screening protocol. Otolar-yngol Head Neck Surg 1999; 121: 693–701.
  • Stavroulaki P, Apostlopoulos N, Dinopoulou D, Vossinakis I, Tsakanikos M, Douniadakis D. Otoacous-tic emissions — An approach for monitoring aminogly-coside induced ototoxity in children. Int J Pediatr Otorhinolaryngol 1999; 50: 177–84.
  • Cianfrone G, Ralli G, Fabbricastore M, Altissimi G, Nala G. Distortion product otoacoustic emissions in Ménière's disease. Scand Audiol 2000; 29: 111–9.
  • Magliulo G, Cianfrone G, Triches L, Altissimi G, D'Amino R. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops. Laryngo-scope 2001; 111: 102–9.
  • Sakashita T, Kubo T, Kyunai K, Ueno K, Hikawa C, Shibata T, Yamane H, Kusuki M, Wada T, Uyama T. Changes in otoacoustic emission during the glycerol test in the ear with patients with Ménière's disease. J Otolaryngol Jpn 2001; 104: 682–93.
  • Hikawa C. A clinical application of distortion product otoacoustic emissions during the glycerol test. J Osaka City Med C 2002; 51: 7–16.
  • Sakashita T, Kubo T, Kusuki M, Kyunai K, Ueno K, Hikawa T, Wada T, Shibata T, Nakai Y. Patterns of change in growth function of distortion product otoa-coustic emissions in Meniere's disease. Acta Otolaryngol 1998; Suppl 538: 70–7.
  • Kusuki M, Sakashita T, Kubo T, Kyunai K, Ueno K, Hikawa T, Wada T, Nakai Y. Changes in distortion product otoacoustic emissions from ears with Meniere's disease. Acta Otolaryngol 1998; Suppl 538: 78–89.
  • 41st World Medical Assembly. Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24: 606–9.
  • Stover L, Norton SJ. The effects of aging on otoacoustic emissions. J Acoust Soc Am 1993; 94: 2670–81.
  • Whitehead ML, McCoy MJ, Lonsbury-Martin BL, Martin GK. Dependence of distortion-product otoa-coustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below Ll. J Acoust Soc Am 1995; 97: 2346–58.
  • Katbamna B, Homnick DN, Marks JH. Effects of chronic tobramycin treatment on distortion product otoacoustic emissions. Ear Hear 1999; 20: 393–402.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.